Study of 9MW2821 plus other drugs for advanced gynecologic cancers
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a new drug combination for women with advanced gynecologic tumors that have not responded to standard treatments. Participants receive 9MW2821 along with other anti-cancer drugs to see if the combination is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 18 and 75 years old.
- You have been diagnosed with advanced gynecologic cancer (like ovarian, uterine, or cervical cancer).
- You are able to go about your daily activities with little or no help (ECOG 0 or 1).
- You have tumor tissue available for testing or agree to have a biopsy.
- You have at least one measurable tumor that can be seen on scans.
- You have not had another cancer in the past 3 years (except some skin cancers or early-stage cervical cancer).
- You do not have serious heart, lung, bleeding, or eye problems, or uncontrolled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies an experimental drug called BL-M09D1. It is given to people with certain gynecologic cancers and other solid tumors that have advanced and not responded to standard treatment. The goal is to see if the drug can help shrink or control the cancer.
This trial tests a new drug, 9MW2821 (sometimes with a PD-1 inhibitor), for people with advanced triple-negative breast cancer. It may be an option if you've already tried standard treatments or haven't started any yet.
This study tests whether a new drug called 9MW2821 works better than standard chemotherapy for triple-negative breast cancer that has spread or cannot be removed by surgery. You would qualify if your cancer has already been treated with certain chemotherapies and your body is healthy enough to tolerate more treatment.
This trial tests a new drug called 9MW2821 for people with high-risk bladder cancer that hasn't grown into the bladder muscle. It's for those who have already tried other treatments that didn't work or who can't have standard therapy.
This trial tests a new drug called 7MW4911 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe and effective, and may be an option if you have a tumor that expresses a certain protein (CDH17).
This trial tests a new combination of two investigational drugs, 7MW3711 and JS207, for people with advanced solid tumors that no longer respond to standard treatments. It aims to see if this combination is safe and effective.
Hear when a new Gynecological Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.